No Record Found
Sector
PharmaceuticalsOpen
₹0.55Prev. Close
₹0.57Turnover(Lac.)
₹30.81Day's High
₹0.55Day's Low
₹0.5552 Week's High
₹1.4452 Week's Low
₹0.48Book Value
₹0.82Face Value
₹1Mkt Cap (₹ Cr.)
67.98P/E
2.5EPS
0.22Divi. Yield
022 Aug 2025
12:00 AM
Split
3 Sep 2025
12:00 AM
AGM
Announcement Date: 03 Sep, 2025
17 Oct 2025
12:00 AM
Board Meeting
Agenda : Audited Result
8 Oct 2025
12:00 AM
Bonus
2 Sep 2025
12:00 AM
BookCloser
In addition, a 10:1 stock split has been cleared, dividing one equity share of ₹10 each into 10 shares of ₹1 each.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 112.44 | 13.44 | 13.44 | 12.12 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -9.93 | -12.1 | -11.92 | -12.03 |
Net Worth | 102.51 | 1.34 | 1.52 | 0.08 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 0.1 | 0.13 | 0.08 | 0.05 |
yoy growth (%) | -21.23 | 61.57 | 65 | -44.19 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.01 | 0 | 0 | 0 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.02 | 0.05 | 0 | -0.01 |
Depreciation | 0 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.02 | 0.03 | -0.01 | -0.02 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -21.23 | 61.57 | 65 | -44.19 |
Op profit growth | -57.05 | -661.27 | -52.28 | -174.27 |
EBIT growth | -57.2 | -684.21 | -51.13 | -169.92 |
Net profit growth | -57.2 | -684.21 | -51.13 | -169.92 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Non Exe. Director
Pradeep Dnyaneshwar Terse
Executive Director & MD
Chintan Didawala
Independent Non Exe. Director
Yogeshkumar Prajapati
Independent Non Exe. Director
Bhumika Pradhan
Independent Non Exe. Director
Ravi Thakor
Company Sec. & Compli. Officer
Palak Jain
B-9 & 10 Laxmi Towers,
L S C Block-C Saraswati Vihar,
New Delhi - 110034
Tel: 91-011-2701 1428
Website: http://www.welcuredrugs.com
Email: investor.welcure@gmail.com; sec_welcure@rediffmail
Noble Heights 1st Fl,
Plot NH 2 C-1 Block, LSC Janakpuri,
New Delhi - 110058
Tel: 91-11-41410592/93/94
Website: www.linkintime.co.in
Email: delhi@linkintime.co.in
Summary
Incorporated on 4 Jun.92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals...
Read More
Reports by Welcure Drugs & Pharmaceuticals Ltd
What is the Welcure Drugs & Pharmaceuticals Ltd share price today?
What is the Market Cap of Welcure Drugs & Pharmaceuticals Ltd?
What is the PE and PB ratio of Welcure Drugs & Pharmaceuticals Ltd?
What is the 52 Week High and Low of Welcure Drugs & Pharmaceuticals Ltd?
What is the CAGR of Welcure Drugs & Pharmaceuticals Ltd?
What is the shareholding pattern of Welcure Drugs & Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
